Literature DB >> 29049045

Nutrition, physical activity, and lifestyle factors in prostate cancer prevention.

Eric Ballon-Landa1, J Kellogg Parsons.   

Abstract

PURPOSE OF REVIEW: To review current evidence for prostate cancer prevention with nutrition, physical activity, and lifestyle interventions and identify future research directions. RECENT
FINDINGS: Multiple preclinical and observational studies have observed that diet, exercise, and lifestyle interventions may play a role in mitigating disease progression, mortality, and overall disease burden for high-grade and fatal prostate cancer. Increased vegetable and fruit intakes, decreased red meat and saturated fat intakes, and increased exercise are potentially associated with decreased risk of incident disease and increased progression-free, prostate cancer-specific, and overall survival. Randomized controlled trials (RCTs) have demonstrated that selenium and vitamin C supplements are ineffective in preventing incident prostate cancer and that vitamin E supplements potentially increase incident prostate cancer risk. A large RCT of a high vegetable diet intervention among prostate cancer patients on active surveillance, the Men's Eating and Living study, will soon complete analysis. An RCT for an exercise intervention among men with metastatic castrate-resistant prostate cancer is currently accruing.
SUMMARY: Although preclinical and observational studies have identified potential benefits for high vegetable, low fat, low meat diets, and increased exercise, Level I evidence is limited. To inform clinical care, future research should focus on RCTs evaluating clinical effectiveness.

Entities:  

Mesh:

Year:  2018        PMID: 29049045     DOI: 10.1097/MOU.0000000000000460

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  15 in total

1.  Multidisciplinary lifestyle modification program (IM-FIT) for cancer survivors: implementation of a reimbursable model in a cancer hospital.

Authors:  Aimee J Christie; Catherine Powers-James; Santhosshi Narayanan; Minxing Chen; Carol Eddy; Telma Gomez; Karla Crawford; Lorenzo Cohen; Gabriel Lopez
Journal:  Support Care Cancer       Date:  2021-05-28       Impact factor: 3.603

Review 2.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

3.  Investigation of Chromosome 1 Aberrations in the Lymphocytes of Prostate Cancer and Benign Prostatic Hyperplasia Patients by Fluorescence in situ Hybridization.

Authors:  Justyna Miszczyk; Mikołaj Przydacz; Michał Zembrzuski; Piotr L Chłosta
Journal:  Cancer Manag Res       Date:  2021-05-31       Impact factor: 3.989

4.  Recreational and occupational physical activity in relation to prostate cancer aggressiveness: the North Carolina-Louisiana Prostate Cancer Project (PCaP).

Authors:  Susan E Steck; L Joseph Su; Samuel O Antwi; Bonny B Morris; Brittany Crawford; Swann Arp Adams; James R Hebert; Elizabeth T H Fontham; Jeannette T Bensen; James L Mohler; Lenore Arab
Journal:  Cancer Causes Control       Date:  2022-03-23       Impact factor: 2.532

5.  A Contribution into Developing a Model for Prostate Cancer Self-Care Mobile Application.

Authors:  Pegah Zargarzadeh; Asghar Ehteshami; Mehrdad Mohammadi-Sichani
Journal:  Med Arch       Date:  2018-11

6.  ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3.

Authors:  Lijie Zhou; Zhengshuai Song; Junyi Hu; Lilong Liu; Yaxin Hou; Xiaoping Zhang; Xiong Yang; Ke Chen
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 7.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11

Review 8.  Natural Products in the Prevention of Metabolic Diseases: Lessons Learned from the 20th KAST Frontier Scientists Workshop.

Authors:  Seung J Baek; Bruce D Hammock; In-Koo Hwang; Qingxiao Li; Naima Moustaid-Moussa; Yeonhwa Park; Stephen Safe; Nanjoo Suh; Sun-Shin Yi; Darryl C Zeldin; Qixin Zhong; Jennifer Alyce Bradbury; Matthew L Edin; Joan P Graves; Hyo-Young Jung; Young-Hyun Jung; Mi-Bo Kim; Woosuk Kim; Jaehak Lee; Hong Li; Jong-Seok Moon; Ik-Dong Yoo; Yiren Yue; Ji-Young Lee; Ho-Jae Han
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

9.  Compliance with the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and Prostate Cancer.

Authors:  Rocío Olmedo-Requena; Macarena Lozano-Lorca; Inmaculada Salcedo-Bellido; Antonio Jiménez-Pacheco; Fernando Vázquez-Alonso; Marta García-Caballos; María-José Sánchez; José-JuanJ Jiménez-Moleón
Journal:  Nutrients       Date:  2020-03-14       Impact factor: 5.717

10.  TP53, SPOP and PIK3CA Genes Status in Prostate Cancer.

Authors:  Mazhar Salim Al Zoubi; Raed Otoum; Mohammed S Alorjani; Samir Al Bashir; Bahaa Al Trad; Manal Issam Abualrja; Sohaib M Al-Khatib; Khalid Al-Batayneh
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.